期刊文献+

芬戈莫德对实验性自身免疫性脑脊髓炎小鼠脑组织基质金属蛋白酶-9表达影响的研究 被引量:2

The Effect of FTY720 on the Expression of MMP-9 in the Brain Tissue of Experimental Autoimmune Encephalomyelitis Mice
原文传递
导出
摘要 目的探讨芬戈莫德对实验性自身免疫性脑脊髓炎(EAE)小鼠脑组织基质金属蛋白酶-9(MMP-9)mRNA及蛋白表达的影响。方法 48只雌性C57BL/6小鼠随机分为完全弗氏佐剂(CFA)组、EAE组、芬戈莫德组。运用髓鞘少突胶质细胞糖蛋白35-55构建EAE小鼠模型,小鼠神经功能缺损评分达到1分或免疫第14天,芬戈莫德组腹腔注射芬戈莫德10 mg·kg-1,相应的CFA组、EAE组给予生理盐水。观察小鼠行为学变化,中枢炎症和脱髓鞘情况,脑组织中的MMP-9 mRNA及蛋白表达。结果芬戈莫德组小鼠临床症状减轻,体重下降减少,潜伏期延长,发病率降低,炎性病灶数减少,脱髓鞘程度减轻。芬戈莫德组MMP-9 m RNA和蛋白表达水平较EAE组降低。结论芬戈莫德能抑制EAE小鼠脑组织中MMP-9 mRNA及蛋白表达水平。 Aim To investigate the effect of fingolimod(FTY720) on the expression of matrix metalloproteinase-9(MMP-9) in the brain tissue of experimental autoimmune encephalomyelitis(EAE). Methods Forty-eight C57BL/6 mice were randomly divided into three groups equally: EAE group(made by using myelin oligodendrocyte glycoprotein(MOG35-55), treated with normal saline), CFA group(made by using normal saline instead of MOG35-55, treated with normal saline), FTY720 group(made as EAE group, intraperitoneal injected FTY720(10 mg·kg-1). Mice were examined daily for clinical signs and scored accordingto the signs and symptoms. Hematoxylin-eosin staining and Luxol Fast Blue myelin staining were performed on the sections of brain. The number of inflammation focus in the brain tissue was counted under the optical microscope. The expressions of MMP-9 in brain tissue were detected by immunohistochemistry technique, while mR NA expression of MMP-9 in mice were detected by real-time PCR technology. Results Comparing to EAE group, neurological deficit scores, weight 1oss, eclipse period and morbidity decreased in FTY720 group, as well as the amount of the inflammation focus and demyelination lesions. The expression level of MMP-9 and MMP-9 mR NA in FTY720 group were lower than that of EAE group. Conclusion FTY720 inhibit the expression level of MMP-9 protein and mR NA in the brain tissue of EAE mice.
出处 《中国临床神经科学》 2015年第4期399-405,共7页 Chinese Journal of Clinical Neurosciences
基金 四川省卫生厅资助项目(编号:110305)
关键词 实验性自身免疫性脑脊髓炎 多发性硬化 基质金属蛋白酶-9 芬戈莫德 细胞外基质 血脑屏障 experimental autoimmune encephalomyelitis multiple sclerosis matrix metalloproteinase-9 fingolimod extracellular matrix blood-brain barrier
  • 相关文献

参考文献24

  • 1Harrison DM. Multiple sclerosis[J]. Ann Intern Med,2014,160: ITC4- 2-ITC4-18.
  • 2Klaren RE, Motl RW, Woods JA, et al. Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis)[J]. J Neuroimmunol,2014,274:14-19.
  • 3Zheng M, Wei J, Tang Y, et al. ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyelitis via alteration ofMMP-9[J]. J Mol Neurosci,2014,54:282-290.
  • 4S~inchez AJ, Puerta C, Ballester S, et al. Rolipram impairs NF- kappaB activity and MMP-9 expression in experimental autoimmune encephalomyelitis [J]. J Neuroimmtmol,2005,168:13 -20.
  • 5Liuzzi GM, Trojano M, Fanelli M, et al. Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis:implication for pathogenesis[J]. Mult Scler,2002,8:222-228.
  • 6Cohen JA, Barkhof F, Comi G, et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis[J]. N Engl J Med,2010,362:402-415.
  • 7谭强,罗家明,余巨明.芬戈莫德治疗多发性硬化的中枢神经系统作用机制研究进展[J].中国临床神经科学,2014,22(2):224-227. 被引量:2
  • 8Lalive PH, Molnarfi N, Benkhoucha M, et al. Antibody response in MOG(35-55) induced EAE[J]. J Neuroimmunol,20l 1,240-241:28-33.
  • 9Urban JL, Kumar V, Kono DH, et al. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy[J]. Ce11,1988,54:577-592.
  • 10Okuda Y, Sakoda S, Fujimura H,et al. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35- 55 induced experimental autoimmune encephalomyelitis[J]. J Neuroimmunol, 1999,101:188-196.

二级参考文献33

  • 1Matloubian M,Lo CG,Cinamon G,et al.Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1[J].Nature,2004,427:355-360.
  • 2Groves A,Kihara Y,Chun J.Fingolimod:direct CNS effects of sphingosine 1-phosphate (S 1P) receptor modulation and implications in multiple sclerosis therapy[J].J Neurol Sci,2013,328:9-18.
  • 3Fujita T,Inoue K,Yamamoto S,et al.Fungal metabolites.Part 11.A potent immunosuppressive activity found in Isaria sinclairii metabolite[J].J Antibiot (Tokyo),1994,47:208-215.
  • 4Sharma S,Mathur AG,Pradhan S,et al.Fingolimod (FTY720):First approved oral therapy for multiple sclerosis[J].J Pharmacol Pharmacother,2011,2:49-51.
  • 5Mandala S,Hajdu R,Bergstrom J,et al.Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists[J].Science,2002,296:346-349.
  • 6Brinkmann V,Davis MD,Heise CE,et al.The immune modulator FTY720 targets sphingosine 1-phosphate receptors[J].J Biol Chem,2002,277:21453-21457.
  • 7Paugh SW,Payne SG,Barbour SE,et al.The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2[J].FEBS Lett,2003,554:189-193.
  • 8Ishii M,Egen JG,Klauschen F,et al.Sphingosine-l-phosphate mobilizes osteoclast precursors and regulates bone homeostasis[J].Nature,2009,458:524-528.
  • 9Graler MH,Goetzl EJ.The immunosuppressant FTY720 downregulates sphingosine 1-phosphate G-protein-coupled receptors[J].FASEB J,2004,18:551-553.
  • 10Oo ML,Thangada S,Wu MT,et al.Immunosuppressive and antiangiogenic sphingosine l-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor[J].J Biol Chem,2007,282:9082-9089.

共引文献1

同被引文献24

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部